The critical role of His48 in mouse cytosolic sulfotransferase SULT2A8 for the 7-hydroxyl sulfation of bile acids

被引:9
作者
Shimohira, Takehiko [1 ,2 ]
Kurogi, Katsuhisa [1 ,2 ]
Liu, Ming-Cheh [3 ]
Suiko, Masahito [1 ,2 ]
Sakakibara, Yoichi [1 ,2 ]
机构
[1] Univ Miyazaki, Dept Biochem & Appl Biosci, Miyazaki, Japan
[2] Univ Miyazaki, Interdisciplinary Grad Sch Agr & Engn, Miyazaki, Japan
[3] Univ Toledo, Coll Pharm & Pharmaceut Sci, Dept Pharmacol, Hlth Sci Campus, Toledo, OH 43606 USA
关键词
Cytosolic sulfotransferase; SULT; cholic acid; bile acid; sulfation; EXPRESSION; PROTEINS; CLONING;
D O I
10.1080/09168451.2018.1464897
中图分类号
Q5 [生物化学]; Q7 [分子生物学];
学科分类号
071010 ; 081704 ;
摘要
Members of the cytosolic sulfotransferase (SULT) SULT2A subfamily are known to be critically involved in the homeostasis of steroids and bile acids. SULT2A8, a 7-hydroxyl bile acid-preferring mouse SULT, has been identified as the major enzyme responsible for the mouse-specific 7-O-sulfation of bile acids. Interestingly, SULT2A8 lacks a conservative catalytic His residue at position 99th. The catalytic mechanism underlying the SULT2A8-mediated 7-O-sulfation of bile acids thus remained unclear. In this study, we performed a mutational analysis in order to gain insight into this yet-unresolved issue. Results obtained revealed two amino acid residues, His48 and Leu99, that are unique to the mouse SULT2A8, but not other SULTs, are essential for its 7-O-sulfating activity toward bile acids. These findings suggested that substitutions of two amino acids, which might have occurred during the evolution of the mouse SULT2A8 gene, endowed mouse SULT2A8 the capacity to catalyze the 7-O-sulfation of bile acids.
引用
收藏
页码:1359 / 1365
页数:7
相关论文
共 29 条
  • [1] A proposed nomenclature system for the cytosolic sulfotransferase (SULT) superfamily
    Blanchard, RL
    Freimuth, RR
    Buck, J
    Weinshilboum, RM
    Coughtrie, MWH
    [J]. PHARMACOGENETICS, 2004, 14 (03): : 199 - 211
  • [2] Borgstrom B., 1985, Sterols and bile acids, V12, P405, DOI DOI 10.1016/S0167-7306(08)60690-0
  • [3] The Farnesoid X receptor - A molecular link between bile acid and lipid and glucose metabolism
    Claudel, T
    Staels, B
    Kuipers, F
    [J]. ARTERIOSCLEROSIS THROMBOSIS AND VASCULAR BIOLOGY, 2005, 25 (10) : 2020 - 2031
  • [4] SULFATED BILE-ACIDS IN GERMFREE AND CONVENTIONAL MICE
    EYSSEN, HJ
    PARMENTIER, GG
    MERTENS, JA
    [J]. EUROPEAN JOURNAL OF BIOCHEMISTRY, 1976, 66 (03): : 507 - 514
  • [5] Sulfation and sulfotransferases .3. Enzymology of human cytosolic sulfotransferases
    Falany, CN
    [J]. FASEB JOURNAL, 1997, 11 (04) : 206 - 216
  • [6] Identification and characterization of a novel PPARα-regulated and 7α-hydroxyl bile acid-preferring cytosolic sulfotransferase mL-STL (Sult2a8)
    Feng, Lu
    Yuen, Yee-Lok
    Xu, Jian
    Liu, Xing
    Chan, Martin Yan-Chun
    Wang, Kai
    Fong, Wing-Ping
    Cheung, Wing-Tai
    Lee, Susanna Sau-Tuen
    [J]. JOURNAL OF LIPID RESEARCH, 2017, 58 (06) : 1114 - 1131
  • [7] Human cytosolic sulfotransferase database mining: identification of seven novel genes and pseudogenes
    Freimuth, RR
    Weipert, M
    Chute, CG
    Wieben, ED
    Weinshilboum, RM
    [J]. PHARMACOGENOMICS JOURNAL, 2004, 4 (01) : 54 - 65
  • [8] Bile acids repress E-cadherin through the induction of Snail and increase cancer invasiveness in human hepatobiliary carcinoma
    Fukase, Koji
    Ohtsuka, Hideo
    Onogawa, Tohru
    Oshio, Hiroshi
    Ii, Takayuki
    Mutoh, Mitsuhisa
    Katayose, Yu
    Rikiyama, Toshiki
    Oikawa, Masaya
    Motoi, Fuyuhiko
    Egawa, Shinichi
    Abe, Takaaki
    Unno, Michiaki
    [J]. CANCER SCIENCE, 2008, 99 (09) : 1785 - 1792
  • [9] Human sulfotransferases and their role in chemical metabolism
    Gamage, N
    Barnett, A
    Hempel, N
    Duggleby, RG
    Windmill, KF
    Martin, JL
    McManus, ME
    [J]. TOXICOLOGICAL SCIENCES, 2006, 90 (01) : 5 - 22
  • [10] Strategies for drug discovery by targeting sulfation pathways
    Hemmerich, S
    Verdugo, D
    Rath, VL
    [J]. DRUG DISCOVERY TODAY, 2004, 9 (22) : 967 - 975